Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system

Obesity

Volumn 16, Issue 8, 2008, Pages 1763-1769

  Gout, Johann ^a,b,c,d   Sarafian, Delphine ^a,b,c,d   Tirard, Julien ^a,b,c,d   Blondet, Antonine ^a,b,c,d   Vigier, Michèle ^a,b,c,d   Rajas, Fabienne ^a,b,c,d   Mithieux, Gilles ^a,b,c,d   Begeot, Martine ^a,b,c,d   Naville, Danielle ^a,b,c,d  

^a INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ DE LYON   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; AGOUTI RELATED PROTEIN, MOUSE; AGOUTI-RELATED PROTEIN, MOUSE; ALPHA INTERMEDIN; DRUG DERIVATIVE; LEPTIN; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; MSH, 4 NLE 7 PHE ALPHA; MSH, 4-NLE-7-PHE-ALPHA-; NORLEUCINE; PROOPIOMELANOCORTIN;

ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; HYPOTHALAMUS; INFUSION; MALE; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSIOLOGY;

AGOUTI-RELATED PROTEIN; ALPHA-MSH; ANIMALS; CELL LINE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HYPOTHALAMUS; INFUSIONS, PARENTERAL; LEPTIN; MALE; MELANOCORTINS; MICE; MICE, INBRED C57BL; NORLEUCINE; OBESITY; PRO-OPIOMELANOCORTIN; RECEPTOR, MELANOCORTIN, TYPE 4; RNA, MESSENGER;

AGOUTI; MUS;

EID: 48749086788     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.303     Document Type: Article

References (38)

1. Forbes S, Bui S, Robinson BR, Hochgeschwender U, Brennan MB. Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci USA 2001;98:4233-4237.
2. Gantz I, Miwa H, Konda Y et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993;268:15174-15179.
3. Huszar D, Lynch CA, Fairchild-Huntress V et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-41.
4. Vaisse C, Clement K, Durand E et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000;106:253-262.
5. Yang YK, Ollmann MM, Wilson BD et al. Effects of recombinant agouti-signaling protein on melanocortin action. Mol Endocrinol 1997;11:274-280.
6. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL. Overexpression of Agrt Leads to obesity in transgenic mice. Nat Genet 1997;17:273-274.
7. Liu H, Kishi T, Roseberry AG et al. Transgenic Mice Expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 2003;23:7143-154.
8. Auwerx J, Staels B. Leptin. Lancet 1998;351:737-742.
9. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse Ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
10. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305-311.
11. Schwartz MW, Seeley RJ, Woods SC et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997;46:2119-2123.
12. Elias CF, Aschkenasi C, Lee C et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999;23:775-786.
13. Seeley RJ, Yagaloff KA, Fisher SL et al. Melanocortin receptors in leptin effects. Nature 1997;390:349.
14. Kask A, Rägo L, Wikberg JE, Schiöth HB. Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur J Pharmacol 1998;360:15-19.
15. Moraes RC, Blondet A, Birkenkamp-Demtroeder K et al. Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology 2003;144:4773-4782.
16. Gertler A, Simmons J, Keisler DH. Large-scale preparation of biologically active recombinant ovine obese protein (leptin). FEBS Lett 1998;422:137-140.
17. Blondet A, Doghman M, Rached M et al. Characterization of cell lines stably expressing human normal or mutated EGFP-tagged MC4R. J Biochem 2004;135:541-546.
18. Rached M, Buronfosse A, Begeot M, Penhoat A. Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity. Biochim Biophys Acta 2004;1689:229-234.
19. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000;105:1827-1832.
20. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 2000;24:639-646.
21. Huang XF, Han M, Storlien LH. The level of NPY receptor mRNA expression in diet-induced obese and resistant mice. Brain Res Mol Brain Res 2003;115:21-28.
22. Enriori PJ, Evans AE, Sinnayah P et al. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab 2007;5:181-194.
23. Seufert J, Kieffer TJ, Leech CA et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab 1999;84:670-676.
24. Huang W, Dedousis N, Bhatt BA, O'Doherty RM. Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity. J Biol Chem 2004;279: 21695-21700.
25. Lebrethon MC, Naville D, Begeot M, Saez JM. Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. J Clin Invest 1994;93:1828-1833.
26. Lebrethon MC, Jaillard C, Naville D, Begeot M, Saez JM. Regulation of corticotropin and steroidogenic enzyme mRNAs in human fetal adrenal cells by corticotropin, angiotensin-II and transforming growth factor β1. Mol Cell Endocrinol 1994;106:137-143.
27. Rainey WE, McAllister JM, Byrd EW, Mason JI, Carr BR. Regulation of corticotropin responsiveness in human fetal adrenal cells. Am J Obstet Gynecol 1991;165:1649-1654.
28. Penhoat A, Jaillard C, Saez JM. Corticotropin positively regulates its own receptors and camp response in cultured bovine adrenal cells. Proc Natl Acad Sci USA 1989;86:4978-4981.
29. Ahren B, Mansson S, Gingerich RL, Havel PJ. Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting. Am J Physiol 1997;273:R113-R120.
30. Wang H, Storlien LH, Huang XF. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am J Physiol Endocrinol Metab 2002;282:E1352-E1359.
31. Harrold JA, Widdowson PS, Williams G. Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes 1999;48:267-271.
32. Pierroz DD, Ziotopoulou M, Ungsunan L et al. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 2002;51:1337-1345.
33. Mithieux G, Misery P, Magnan C et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab 2005;2:321-329.
34. Ibrahim N, Bosch MA, Smart JL et al. Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology 2003;144:1331-1340.
35. Morgan K, Obici S, Rossetti L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem 2004;279:31139-31148.
36. Hu Z, Cha SH, Chohnan S, Lane MD. Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc Natl Acad Sci USA 2003;100:12624-12629.
37. Cai F, Gyulkhandanyan AV, Wheeler MB, Belsham DD. Glucose regulates AMP-activated protein kinase activity and gene expression in clonal, hypothalamic neurons expressing proopiomelanocortin: additive effects of leptin or insulin. J Endocrinol 2007;192:605-614.
38. Ziotopoulou M, Mantzoros CS, Hileman SM, Flier JS. Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 2000;279:E838-E845.